The US and UK Insist Aspartame is Safe Despite Reports of Serious Side Effects

Aspartame, the controversial artificial sweetener that is broken down to methanol and formaldehyde, has prompted thousands of reports to the FDA about adverse reactions, including Dr. Russell Blalock’s 1994 book Excitotoxins. In some people, aspartame, which is found in over 4,000 consumer products, causes symptoms ranging from headaches to dizziness, vomiting, fatigue and diarrhea.

Read More

Knee-Repair Device Reveals Political Pressures at the FDA

There’s an old adage, “Any publicity is good publicity,” but the exposure of four New Jersey lawmakers on the front page of the New York Times was anything but good news for them.  The article reported that Menaflex, a medical device that reinforces damaged knee tissue, was approved only after the two senators and two […]

Read More

ANH-USA Sues FDA

ANH-USA has filed three lawsuits against the FDA in recent weeks. In each case, we have been joined as plaintiffs by dietary supplement formulators Durk Pearson and Sandy Shaw and the Coalition to End FDA and FTC Censorship. We are being represented by the law firm of Emord & Associates.

Read More

FDA Attacks Natural Thyroid Millions Depend On

We have learned that Time-Cap Labs, producer of a generic version of the brand name drug Armour, a natural and bioidentical thyroid replacement, has been ordered by the FDA to stop production. The FDA has decided to classify the company’s product, available for over a century, as an unapproved new drug.  Since the new drug […]

Read More

Alert! Food Safety Bill Bad for Supplements (Ties U.S. to Codex) and Gives FDA Control Over Farming

The Senate’s “Food Safety” bill is better than the House’s in some important respects. For example, it drops the draconian jail sentences and fines for vague infractions including paperwork errors. But it includes a Codex provision that absolutely must be removed by amendment in order to protect free choice about supplements. Please take action to […]

Read More

Thank you for telling the FDA that transparency matters to you!

Thank you to our 801 advocates who used AAHF’s Action Center to submit comments in response to Docket Number FDA-200-N-0247, letting the Food and Drug Administration’s Transparency Task Force know that you support increased transparency at the FDA. On August 6, AAHF proudly hand-delivered 801 letters to the FDA’s Division of Docket Management. These comments […]

Read More